Product Information
DYANAVEL XR 20 MG TABLET is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $14.7895 per EA under NDC 24478011001. Its NADAC has been published 177 times since May 17, 2023.
FDA first approved this application on Nov 4, 2021.
Strength
20 mg/1
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478011001
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA210526FDA Approved
11/4/2021
On Market Since
11/4/2021
Pharmacological Classes
Price Statistics
The NADAC for DYANAVEL XR 20 MG TABLET has been published 177 times since May 17, 2023, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.7895 per EA |
|---|---|
| All-time high | $14.8411 (May 13, 2026) |
| All-time low | $13.4870 (May 17, 2023) |
| 52-week high | $14.8411 |
| 52-week low | $14.5454 |
| Median price | $14.2474 |
| Average price | $14.2800 |
| Largest weekly change | +4.7% (Jan 17, 2024) |
| Weeks tracked | 177 |
| Tracking since | May 17, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amphetamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NextWave Pharmaceuticals, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amphetamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DYANAVEL XR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DYANAVEL XR 20 MG TABLET, manufactured by NextWave Pharmaceuticals, Inc, is $14.7895 per EA (NDC 24478011001), effective Sep 30, 2026.
How has the price of DYANAVEL XR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for DYANAVEL XR 20 MG TABLET has risen 9.7%. It has been tracked across 177 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for DYANAVEL XR 20 MG TABLET?
Since May 17, 2023, the NADAC for DYANAVEL XR 20 MG TABLET has ranged from a low of $13.4870 (May 17, 2023) to a high of $14.8411 (May 13, 2026), with a median of $14.2474 per EA.
Are there cheaper alternatives to DYANAVEL XR 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DYANAVEL XR 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DYANAVEL XR 20 MG TABLET?
DYANAVEL XR 20 MG TABLET (NDC 24478011001) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.